Lei Chen
Director/Board Member at SHANGHAI XFH TECHNOLOGY CO., LTD
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kun Meng | M | 61 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 years |
| Zhao Yi Wang | M | 65 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 years |
| Peng Wei Zhou | M | 43 |
Tsinghua University
| 16 years |
| Wen Guo Ye | M | 55 | 14 years | |
| Dong Hui Zhao | M | 40 | 14 years | |
| Larry Zhang | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Ye Yan | F | 66 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Xu Tian | F | 64 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Jian Xun Liu | M | 69 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Lei Zhu | F | 44 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 10 years |
| Shu Xue Wang | M | 48 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 9 years |
| Xian Li Si | M | 50 | 2 years | |
| Yong Peng | M | 62 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
| Jun Fei Feng | M | 41 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Jun Ying Sun | F | 63 | 4 years | |
| Deng Yun Zhai | M | 45 | 1 years | |
| Jun Xie | M | 55 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Jian Guang Li | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Bao Ping Wang | M | 63 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
| Robert Eisenman | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Meng Jun Xue | M | 53 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| San Guo Zhu | M | 74 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 8 years |
| Zhi Hang Zhang | M | 37 | 2 years | |
| Yin Li | F | 33 | 3 years | |
| Wing Yu Leung | F | 53 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Bing Wu | M | 50 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Yan Min Tang | F | 51 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Hong Fang Song | M | 36 | 11 years | |
| Ke Jun Teng | M | 46 | 12 years | |
| Dong Xiang | M | 52 |
Tsinghua University
| 19 years |
| Xiao Fei Chen | F | 42 | 5 years | |
| Yan Li | F | 41 | 7 years | |
| Geng Lin Zhu | M | 34 | 7 years | |
| Fang Wu | F | 57 | 14 years | |
| Daqing Cai | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Zuo Ping Xiao | M | 49 |
Tsinghua University
| 19 years |
| Cai Min Zhong | M | 55 |
Tsinghua University
| 19 years |
| Jun Feng Wang | M | 50 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Yi Zhen Gao | M | 28 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yong Bo Xiao | M | 46 |
Tsinghua University
| 9 years |
| Qiang Kong | M | 50 |
Tsinghua University
| 5 years |
| Yue Qi Tan | M | 53 | 4 years | |
| Xin Lu Li | M | 49 | 6 years | |
| Xiang Long Zheng | M | 45 |
Tsinghua University
| 4 years |
| Chao Shen | M | 43 |
Tsinghua University
| 6 years |
| Min Li | M | 44 |
Tsinghua University
| 5 years |
| Yong Ge | M | 54 | - | |
| Carrie Liqun Liu | F | 42 |
Tsinghua University
| 7 years |
| Wen Li You | F | 43 |
Tsinghua University
| 3 years |
| Yuansheng Xue | M | 38 |
Tsinghua University
| 7 years |
| Yan Jing Jia | F | - |
Tsinghua University
| 6 years |
| Yang Xiao | M | 43 |
Tsinghua University
| 1 years |
| Xu Ping Chen | M | 41 |
Tsinghua University
| 4 years |
| Chase Cho | M | - |
Tsinghua University
| 2 years |
| Bing Yu | M | 44 |
Tsinghua University
| 1 years |
| Zhi Xiang Liu | M | 48 |
Tsinghua University
| 1 years |
| Yan Hui Liu | M | 60 |
Tsinghua University
| 2 years |
| Yong Hui Liu | M | 63 |
Tsinghua University
| 2 years |
| Ji Ming Xu | M | 40 |
Tsinghua University
| 4 years |
| Yue Zhou | M | 46 |
Tsinghua University
| 2 years |
| Jie Feng Xi | M | - |
Tsinghua University
| 1 years |
| Sheng Chun Teng | M | 46 |
Tsinghua University
| 2 years |
| Run shi Hou | M | 46 |
Tsinghua University
| 4 years |
| Yan Zhu | F | 60 |
Tsinghua University
| 1 years |
| Yong Tian | M | 45 |
Tsinghua University
| 4 years |
| Xing Da He | M | 45 |
Tsinghua University
| 2 years |
| Zhi Zhuang | M | 55 |
Tsinghua University
| 3 years |
| Shuo Mao | M | - |
Tsinghua University
| 4 years |
| Yizhe Wang | M | 45 |
Tsinghua University
| 1 years |
| Hai Wang | M | 51 |
Tsinghua University
| 2 years |
| Wen Chao Yang | M | 63 |
Tsinghua University
| 2 years |
| Sheng Ming Xu | M | 62 |
Tsinghua University
| 1 years |
| Deli Du | M | 59 |
Tsinghua University
| 2 years |
| Lie Zhang | M | 49 |
Tsinghua University
| 3 years |
| Jun Wang | M | 52 |
Tsinghua University
| 3 years |
| Shao Peng Chen | M | 55 |
Tsinghua University
| 2 years |
| Han Chun Li | M | 50 |
Tsinghua University
| 1 years |
| Kin Chu Chan | M | 54 |
Tsinghua University
| 3 years |
| Li Zhang | M | - |
Tsinghua University
| 2 years |
| Hong Bing Tao | M | 57 |
Tsinghua University
| 2 years |
| Fei Gao | M | 43 |
Tsinghua University
| 2 years |
| Chunbin Yang | M | 61 |
Tsinghua University
| 2 years |
| Jiayi Chen | M | - |
Tsinghua University
| 4 years |
| Xiao Bo Zhao | M | 54 |
Tsinghua University
| 2 years |
| Ellen Qian | F | - |
Tsinghua University
| 4 years |
| Jian Zhu | M | 56 |
Tsinghua University
| 1 years |
| Wen Juan Ruan | F | 45 |
Tsinghua University
| 1 years |
| Ya Hong Hao | F | 57 |
Tsinghua University
| 2 years |
| Lu Ming Zhou | M | 65 |
Tsinghua University
| 2 years |
| Hong Fu Ma | M | 58 |
Tsinghua University
| 2 years |
| Lue Chen | M | 54 |
Tsinghua University
| 1 years |
| Xin Dong Yu | M | 59 |
Tsinghua University
| 2 years |
| Min Ling Peng | F | 57 |
Tsinghua University
| 2 years |
| Ngo Yin Tsang | F | 50 |
Tsinghua University
| 3 years |
| Wei Xing Liu | M | 64 |
Tsinghua University
| 3 years |
| Xu Zhong Qin | M | 52 |
Tsinghua University
| 2 years |
| Pui Ming Fok | F | 45 |
Tsinghua University
| 1 years |
| Zi Hua Su | M | 44 |
Tsinghua University
| 4 years |
| Chun Guo Chen | M | 51 |
Tsinghua University
| 2 years |
| Wei Jiang Pan | M | 45 |
Tsinghua University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lei Chen
- Personal Network
